Table:
begin	end	state
1	23	cytoplasmic
24	43	transmembrane
44	48	non-cytoplasmic
49	67	transmembrane
68	100	cytoplasmic
101	120	transmembrane
121	139	non-cytoplasmic
140	157	transmembrane
158	164	cytoplasmic
165	185	transmembrane
186	206	non-cytoplasmic
207	233	transmembrane
234	253	cytoplasmic
254	275	transmembrane
276	299	non-cytoplasmic
300	321	transmembrane
322	347	cytoplasmic
348	371	transmembrane
372	375	non-cytoplasmic
376	394	transmembrane
395	405	cytoplasmic
406	428	transmembrane
429	429	non-cytoplasmic

Input:
>BWI76_RS22875
METTQTSTIVSDATRSGWRKTDTMWMLGLYGTAIGAGVLFLPINAGVGGMIPLIIMAILA
FPMTFFAHRGMTRFVLSGKNPGEDITEVVEEHFGVGAGKLITLLYFFAIYPILLVYSVAI
TNTVESFMLHQLHITPPPRAILSLILIVGMMTIVRFGEQMIVKAMSVLVFPFVVALMILA
FYLIPQWNGAALETLSLSSATATGNGLWMTLWLAIPVMVFSFNHSPIISSFAVAKREEYG
QGAEKKCSSILARAHIMMVLTVMFFVFSCVLSLSPADLAAAKDQNISILSYLANHFNAPV
IAWMAPIIAMIAITKSFLGHYLGAREGFNGMVIKSLRGKGKSIEINKLNKITALFMLVTT
WIVATLNPSILGMIETLGGPIIAMILFLMPMYAIQKVPAMRKYSGHVSNVFVVIMGLIAI
SAIFYSLFS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server